This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
Leggi →
Maggio 2024